Anchor price 84.50 on closest trading day on/after 2025-03-06. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | Goncalves Joana | officer | Option exercise | 3,500 | $6.84 | $24K |
| 2026-07-15 | Goncalves Joana | officer | Option exercise | 3,500 | $7.80 | $27K |
| 2026-07-15 | Goncalves Joana | officer | Sale | 400 | $84.36 | $34K |
| 2026-07-15 | Goncalves Joana | officer | Sale | 2,497 | $85.86 | $214K |
| 2026-07-15 | Goncalves Joana | officer | Sale | 3,803 | $86.68 | $330K |
| 2026-07-15 | Goncalves Joana | officer | Sale | 300 | $87.25 | $26K |
| 2026-07-01 | Sandler Laura Lee | officer | Option exercise | 5,000 | $7.80 | $39K |
| 2026-07-01 | Sandler Laura Lee | officer | Sale | 2,237 | $93.85 | $210K |
| 2026-07-01 | Sandler Laura Lee | officer | Sale | 2,263 | $94.75 | $214K |
| 2026-07-01 | Sandler Laura Lee | officer | Sale | 500 | $95.47 | $48K |
| 2026-07-01 | Fairmount Funds Management LLC | director, 10%+ owner | C | 3,553,410 | — | — |
| 2026-07-01 | Fairmount Funds Management LLC | director, 10%+ owner | Sale | 3,553,410 | $84.43 | $300.01M |
| 2026-07-01 | Fairmount Funds Management LLC | director, 10%+ owner | C | 42,641 | — | — |
| 2026-06-22 | Agarwal Arjun | officer | Sale | 888 | $80.01 | $71K |
| 2026-06-22 | Agarwal Arjun | officer | Sale | 699 | $82.14 | $57K |
| 2026-04-15 | Goncalves Joana | officer | Option exercise | 3,500 | $6.84 | $24K |
| 2026-04-15 | Goncalves Joana | officer | Option exercise | 3,500 | $7.80 | $27K |
| 2026-04-15 | Goncalves Joana | officer | Sale | 4,227 | $65.73 | $278K |
| 2026-04-15 | Goncalves Joana | officer | Sale | 2,273 | $66.56 | $151K |
| 2026-04-15 | Goncalves Joana | officer | Sale | 500 | $67.38 | $34K |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-01 | SCHEDULE 13D/A | Fairmount Funds Management LLC | 19.50% | 14,553,895 | view → |
| 2022-07-08 | SC | Funicular Funds, LP | — | — | view → |
| 2022-04-14 | SC | Funicular Fund, LP | — | — | view → |
| 2022-04-04 | SC | Funicular Fund, LP | — | — | view → |
| 2018-03-05 | SC | Growth Equity Opportunities IV, LLC | — | — | view → |
| 2018-01-04 | SC | SABBY MANAGEMENT, LLC | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-20 | SCHEDULE 13D/A | Crescent Biopharma, Inc. | — | 6,593,385 | view → |
| 2026-07-01 | SCHEDULE 13D/A | ORUKA THERAPEUTICS, INC. ORKA | 19.50% | 14,553,895 | view → |
| 2026-06-23 | SCHEDULE 13D/A | SPYRE THERAPEUTICS, INC. SYRE | — | 8,835,440 | view → |
| 2026-06-23 | SCHEDULE 13D/A | Apogee Therapeutics, Inc. APGE | 9.99% | 6,713,519 | view → |
| 2026-06-09 | SCHEDULE 13D/A | Jade Biosciences, Inc. JBIO | 19.99% | 14,069,494 | view → |
| 2026-05-13 | SCHEDULE 13D/A | Viridian Therapeutics, Inc.\DE VRDN | — | 17,201,800 | view → |
| 2026-01-22 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 6,047,027 | view → |
| 2026-01-22 | SCHEDULE | Cogent Biosciences, Inc. COGT | 9.90% | 16,261,918 | view → |
| 2025-10-14 | SCHEDULE | Apogee Therapeutics, Inc. APGE | 9.99% | 5,776,881 | view → |
| 2025-09-15 | SCHEDULE | Dianthus Therapeutics, Inc. /DE/ DNTH | 9.90% | 4,052,052 | view → |
| 2024-04-01 | SC | Dianthus Therapeutics, Inc. /DE/ DNTH | — | — | view → |
| 2024-04-01 | SC | Viridian Therapeutics, Inc.\DE VRDN | — | — | view → |
| 2024-04-01 | SC | Apogee Therapeutics, Inc. APGE | — | — | view → |
| 2024-04-01 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
| 2023-12-11 | SC | Spyre Therapeutics, Inc. SYRE | — | — | view → |
| 2023-06-13 | SC | Cogent Biosciences, Inc. COGT | — | — | view → |
| 2021-09-23 | SC | Viridian Therapeutics, Inc.\DE VRDN | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →